Management & Leadership

Mr. Silverman has been our director since May 28, 2020, and currently serves as our Executive Chairman and Principal Executive Officer. Prior to his appointment to such positions on December 13, 2023, Mr. Silverman served as Chairman of the Board. Prior to the Merger, Mr. Silverman had served as a member of the DropCar Board of Directors since the 2018 Merger. Mr. Silverman currently serves as the managing member of Parkfield Funding LLC. Mr. Silverman was the co-founder of, and was previously a principal and managing partner of, Iroquois Capital Management, LLC (“Iroquois”), an investment advisory firm. From its inception in 2003 until July 2016, Mr. Silverman served as co-chief investment officer of Iroquois. While at Iroquois, he designed and executed complex transactions, structuring and negotiating investments in both public and private companies, and was often called upon by such companies to solve inefficiencies relating to corporate structure, cash flow, and management. From 2000 to 2003, Mr. Silverman served as co-chief investment officer of Vertical Ventures, LLC, a merchant bank. Prior to forming Iroquois, Mr. Silverman was a director of Joele Frank, a boutique consulting firm specializing in mergers and acquisitions. Previously, Mr. Silverman served as assistant press secretary to the President of the United States. Mr. Silverman currently serves as a director of MYMD Pharmaceuticals, Inc. (NASDAQ: MYMD), Pharmacyte, Inc. (NASDAQ: PMCB), Synaptogenix, Inc. (NASDAQ: SNPX) and Petros Pharmaceutical, Inc. (NASDAQ: PTPI), all of which are public companies. He previously served as a director of National Holdings Corporation from July 2014 through August 2016 and as a director of Marker Therapeutics, Inc. from August 2016 until October 2018. Mr. Silverman received his B.A. from Lehigh University in 1992. Mr. Silverman’s qualifications to sit on the Board include his experience as an investment banker, management consultant and director of numerous public companies.

Mr. Giordano served as a member of the DropCar Board of Directors since the completion of the business combination with DropCar, Inc. and DC Acquisition Corporation in 2018 and has continued to serve as a director of the Company following the Merger. Mr. Giordano served as the Interim Chief Executive Officer of WPCS from August 2013 until April 25, 2016, when the interim label was removed from his title. He served as the Chief Executive Officer of WPCS through the closing of the 2018 Merger. Mr. Giordano has served as Chairman and Chief Executive Officer of Transportation and Logistics Systems, Inc. (OTC PINK: TLSS) since January 2022. Since 2002, he has been Chief Executive Officer of Ascentaur, LLC, a business consulting firm providing strategic, financial, and business development services to start-up, turnaround, and emerging growth companies. Mr. Giordano received B.B.A. and MBA degrees from Iona College. His qualifications to sit on the Board include his broad management experience, including having served as Chief Executive Officer of WPCS.

Mr. Ramelli was appointed Chief Financial Officer in August 2024. Mr. Ramelli has nearly 30 years of experience in the Biotechnology, Biopharmaceutical and Financial Services industries. He is a seasoned investor and consultant who specializes in business strategic planning and development, capital raising, talent acquisition, and corporate governance. Mr. Ramelli is currently an investor and strategic advisor with Ramelli Asset Management. Since 2023, he has also served as the Vice President of Business Development at Origin Agritech Ltd. Previously, Mr. Ramelli served as Interim Chief Financial Officer from 2020 to 2021 and was a founding member of ValenzaBio, where he established and grew all the finance functions of the company. He also served as Chief Executive Officer of Marina Biotech from 2016 to 2018. Mr. Ramelli graduated from the University of California, Santa Barbara with a B.A. in Business Economics.

Mr. Villarreal was appointed to the position of President of the Company’s subsidiary, AYRO Operating Company, Inc., effective as August 21, 2024, and previously served as a former consultant to the Company. Mr. Villarreal has over 32 years of manufacturing experience across Aerospace, Automotive, and Marine industries. He is the co-founder and chief executive officer of VLF Automotive LLC and the founder of GLV Ventures, a leader in the design and production of a variety of vehicles including electric vehicles. Mr. Villarreal is a former United States Marine and holds a B.A. in Business Administration.

Mr. Schiffman served as a member of the DropCar Board of Directors since the closing of the 2018 Merger and has continued as a director following the Merger. He serves as a senior advisor to Absci Corporation and previously served as its Chief Financial Officer from April 2020 until August 2023. Mr. Schiffman holds a B.S. in Accounting from DePaul University and an MM (MBA) from Northwestern University Kellogg Graduate School of Management.

Mr. Joseph has served as Deputy General Counsel of Amdocs Limited since October 2005 and has continued as a director following the Merger. He holds a J.D. from Fordham University School of Law and multiple certifications in business and corporate governance from Columbia University and Harvard Business School.

Mr. Devlin has managed his consulting business, Venture Connections (G&L Devlin Limited), since 2007, assisting early-stage companies with fundraising and strategic planning. He previously held senior operations roles at Texas Pacific Group and Compaq Computer Corporation. Mr. Devlin graduated with a Business Studies diploma and a postgraduate diploma in Human Resources from Glasgow Polytechnic (Caledonian University).

Mr. Walker has over 35 years of experience in corporate governance, turnaround management, and restructuring. He founded Walker Nell Partners, Inc. in 1998 and has served as its president since. Mr. Walker serves on multiple public and private company boards including Wrap Technologies, Inc. (NASDAQ: WRAP) and Petros Pharmaceuticals, Inc. (NASDAQ: PTPI). He holds a Doctor of Jurisprudence from Catholic University and a B.A. from Loyola University.